GlassScriptPhysician profile
Jeffrey J Thibodeaux
NPI 1275634107
$7,869.36
in general payments reported to CMS, 2019-2025
40 companies · $1,228 in 2025
The $1,228 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $928 · 2021: $951 · 2022: $1,061 · 2023: $1,950 · 2024: $1,001 · 2025: $1,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,659 · Travel and Lodging: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,658.95 |
| Travel and Lodging | $519.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,192.54 | 2021-2024 | Urolift |
| Astellas Pharma US INC | $872.60 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $680.95 | 2019-2025 | Lupron Depot, Botox |
| Sumitomo Pharma America, INC. | $517.96 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $464.76 | 2019-2025 | |
| Coloplast Corp | $446.59 | 2019-2025 | |
| Neotract INC. | $398.95 | 2019-2020 | |
| Janssen Biotech, INC. | $318.69 | 2019-2025 | Erleada, Tremfya |
| Dendreon Pharmaceuticals LLC | $294.72 | 2020-2025 | Provenge |
| Endo Pharmaceuticals INC. | $250.80 | 2019-2024 | Xiaflex |
| Procept Biorobotics Corporation | $245.75 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Allergan, INC. | $220.95 | 2019-2022 | |
| Calyxo, INC. | $178.54 | 2025 | Cvac Aspiration System |
| Accord Healthcare, INC. | $173.13 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $148.42 | 2020-2025 | Keytruda, Lynparza |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $136.19 | 2021-2025 | Jelmyto |
| Boston Scientific Corporation | $131.18 | 2021-2025 | Ams 800 Artificial Urinary Sphincter |
| Blue Earth Diagnostics | $130.79 | 2019-2022 | |
| Kerecis Limited | $99.76 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Antares Pharma, INC. | $94.20 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Olympus America INC. | $85.40 | 2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $82.53 | 2021-2025 | |
| Myovant Sciences INC. | $77.04 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $74.65 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $66.51 | 2019-2025 | Adstiladrin |
| Urovant Sciences INC | $64.07 | 2021-2022 | |
| Profound Medical Corp. | $53.66 | 2025 | Tulsa-Pro |
| Novartis Pharmaceuticals Corporation | $49.89 | 2024-2025 | |
| Medtronic USA, INC. | $48.01 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $47.12 | 2022-2024 | |
| Hollister Incorporated | $40.04 | 2021-2022 | |
| Endo USA, INC. | $36.46 | 2024-2025 | Xiaflex |
| Astrazeneca Pharmaceuticals LP | $29.09 | 2022 | |
| Amgen INC. | $27.11 | 2021-2022 | |
| Zyla Life Sciences, INC. | $24.65 | 2019 | |
| Axonics, INC. | $17.99 | 2021 | |
| Telix Pharmaceuticals | $13.67 | 2023 | Illuccix |
| Clarus Therapeutics INC. | $12.70 | 2021 | |
| Photocure INC | $11.01 | 2019 | |
| Civco Medical Instruments | $10.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Thibodeaux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.